Illegal Activity
suspicious
Blackmail
none
Date
2017-09-18
Document Type
email
Model
gemini-2.0-flash-001
Processed
2026-02-07T18:44
Summary
The email forwards a message about prescriptions from Dr. Josephson's compounding lab, Hopewell pharmacy, including costs and insurance coverage. It seeks approval to purchase the medications, noting that Jeffrey Epstein's insurance information is available.
Metadata
- Subject
- Fwd: Prescriptions Dr. Josephson wants you to have
- Sender
- —
- Recipients
- —
- Document ID
- EFTA02223518
- Date
- 2017-09-18
Illegal Activity
- Severity
- suspicious
- Description
- The email discusses prescriptions from a compounding pharmacy, which can sometimes be associated with questionable practices. The sender is asking for approval to purchase the medications, which could be for someone other than the recipient.
- Content Type
- first_hand
Relationships 2
| Entity 1 | Relationship | Entity 2 | Description |
|---|---|---|---|
| Dr. Josephson | business | Hopewell pharmacy | Dr. Josephson wants prescriptions purchased from his compounding lab, Hopewell pharmacy. |
| Jeffrey E. | financial | insurance | JE's insurance info is available. |
Notable Quotes 2
Yes, they have JE's insurance info! ;)
Dr. Josephson wants you to purchase prescriptions from his compounding lab, Hopewell pharmacy in NJ...
Financial Information
Amounts:2853010
Transactions:
- Purchase of Tobramycin for $285
- Purchase of Budesonide with a copay of $30
- Shipping cost of $10
Raw Analysis JSON
click to expand
Themes
Financial transactions/money flowCommunications/correspondencePersonal relationships
People 2
Organizations 1
Hopewell pharmacy
Locations 1
NJ
Text Analysis
- Tone
- Informative
- Purpose
- To inform about prescriptions and costs, and to get approval for purchase.
- Significance
- The email discusses prescriptions and insurance coverage, indicating a potential financial transaction.
File Info
- File Name
- EFTA02223518.txt
- Dataset
- dataset_11
- Type
- Text
- Model
- gemini-2.0-flash-001
- Processed
- 2026-02-07T18:44:06.452275
- DOJ Source
- View on DOJ